Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide
<p>Abstract</p> <p>Background</p> <p>The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-02-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/7/1/17 |
id |
doaj-4c893e8c807d432998a834565630ab8c |
---|---|
record_format |
Article |
spelling |
doaj-4c893e8c807d432998a834565630ab8c2020-11-24T21:49:13ZengBMCMolecular Cancer1476-45982008-02-01711710.1186/1476-4598-7-17Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptideSeifalian Alexander MFuller Barry JSales Kevin MYang Shi YuWinslet Marc C<p>Abstract</p> <p>Background</p> <p>The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This study was carried out to investigate the effect of a novel IGF-I receptor antagonist on apoptosis in colon cancer cells.</p> <p>Results</p> <p>We have designed and synthesised a novel antagonist of IGF-I receptor. The effect of this antagonist on human colon cancer cell proliferation was examined by a non-radioactive assay; the apoptosis was revealed by determining the activities of cellular caspases3/7, 8 and 9. The apoptosis pathways were investigated by examining the levels of pro-apoptosis proteins with Western blotting. Following 40 hours treatment with the novel antagonist peptide, colon cancer cell Caspase 3/7 activities increased 2–7 times; Caspase 8 activities increased 2–5 times and Caspase 9 increased 1.2–1.6 times. The proliferation of cancer cell was inhibited by 14–15%. The data showed that the antagonist induced colon cancer cell apoptosis and inhibited cancer cell proliferation. The different changes of Caspase 3/7, 8 and 9 activities suggested that the extrinsic pathways may play a major role in the antagonist peptide-induced apoptosis.</p> <p>Conclusion</p> <p>This is the first report on this novel antagonist to induce human colon cancer cell apoptosis and inhibit cancer cell proliferation. These results suggest that IGF-I receptor antagonists may have the potential to be developed as a novel therapy for colon cancers in the future.</p> http://www.molecular-cancer.com/content/7/1/17 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Seifalian Alexander M Fuller Barry J Sales Kevin M Yang Shi Yu Winslet Marc C |
spellingShingle |
Seifalian Alexander M Fuller Barry J Sales Kevin M Yang Shi Yu Winslet Marc C Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide Molecular Cancer |
author_facet |
Seifalian Alexander M Fuller Barry J Sales Kevin M Yang Shi Yu Winslet Marc C |
author_sort |
Seifalian Alexander M |
title |
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide |
title_short |
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide |
title_full |
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide |
title_fullStr |
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide |
title_full_unstemmed |
Inducing apoptosis of human colon cancer cells by an IGF-I D domain analogue peptide |
title_sort |
inducing apoptosis of human colon cancer cells by an igf-i d domain analogue peptide |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2008-02-01 |
description |
<p>Abstract</p> <p>Background</p> <p>The resistance of tumour cells to apoptosis is a major contributor to the limited effectiveness of chemotherapies. Insulin-like growth factor I (IGF-I) has potential to protect cancer cells from variety of apoptotic challenges. This study was carried out to investigate the effect of a novel IGF-I receptor antagonist on apoptosis in colon cancer cells.</p> <p>Results</p> <p>We have designed and synthesised a novel antagonist of IGF-I receptor. The effect of this antagonist on human colon cancer cell proliferation was examined by a non-radioactive assay; the apoptosis was revealed by determining the activities of cellular caspases3/7, 8 and 9. The apoptosis pathways were investigated by examining the levels of pro-apoptosis proteins with Western blotting. Following 40 hours treatment with the novel antagonist peptide, colon cancer cell Caspase 3/7 activities increased 2–7 times; Caspase 8 activities increased 2–5 times and Caspase 9 increased 1.2–1.6 times. The proliferation of cancer cell was inhibited by 14–15%. The data showed that the antagonist induced colon cancer cell apoptosis and inhibited cancer cell proliferation. The different changes of Caspase 3/7, 8 and 9 activities suggested that the extrinsic pathways may play a major role in the antagonist peptide-induced apoptosis.</p> <p>Conclusion</p> <p>This is the first report on this novel antagonist to induce human colon cancer cell apoptosis and inhibit cancer cell proliferation. These results suggest that IGF-I receptor antagonists may have the potential to be developed as a novel therapy for colon cancers in the future.</p> |
url |
http://www.molecular-cancer.com/content/7/1/17 |
work_keys_str_mv |
AT seifalianalexanderm inducingapoptosisofhumancoloncancercellsbyanigfiddomainanaloguepeptide AT fullerbarryj inducingapoptosisofhumancoloncancercellsbyanigfiddomainanaloguepeptide AT saleskevinm inducingapoptosisofhumancoloncancercellsbyanigfiddomainanaloguepeptide AT yangshiyu inducingapoptosisofhumancoloncancercellsbyanigfiddomainanaloguepeptide AT winsletmarcc inducingapoptosisofhumancoloncancercellsbyanigfiddomainanaloguepeptide |
_version_ |
1725888710818398208 |